- call +1-201-465-4211
- email sales@mrinsights.biz
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Scope of the Report:
The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017.
Tuberculosis Diagnostics is widely used in hospital, diagnostic laboratories and other field. The most proportion of Tuberculosis Diagnostics is hospital, and the revenue in 2017 is 542 M USD.
Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%.
The global Tuberculosis Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Tuberculosis Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Epistem
Akonni Biosystems
Creative Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Culture-based
Sputum Smear Microscopy
Rapid Molecular
Others
Market Segment by Applications, can be divided into
Hospital
Diagnostic Laboratories
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tuberculosis Diagnostics Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics
1.2 Classification of Tuberculosis Diagnostics by Types
1.2.1 Global Tuberculosis Diagnostics Revenue Comparison by Types (2019-2024)
1.2.2 Global Tuberculosis Diagnostics Revenue Market Share by Types in 2018
1.2.3 Culture-based
1.2.4 Sputum Smear Microscopy
1.2.5 Rapid Molecular
1.2.6 Others
1.3 Global Tuberculosis Diagnostics Market by Application
1.3.1 Global Tuberculosis Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Diagnostics Market by Regions
1.4.1 Global Tuberculosis Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Tuberculosis Diagnostics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnostics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnostics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnostics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnostics Status and Prospect (2014-2024)
1.5 Global Market Size of Tuberculosis Diagnostics (2014-2024)
2 Manufacturers Profiles
2.1 Danaher
2.1.1 Business Overview
2.1.2 Tuberculosis Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Danaher Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Tuberculosis Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Thermo Fisher Scientific
2.3.1 Business Overview
2.3.2 Tuberculosis Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Thermo Fisher Scientific Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.4 BD
2.4.1 Business Overview
2.4.2 Tuberculosis Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BD Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Tuberculosis Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Hologic
2.6.1 Business Overview
2.6.2 Tuberculosis Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hologic Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Qiagen
2.7.1 Business Overview
2.7.2 Tuberculosis Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Qiagen Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.8 BioMerieux
2.8.1 Business Overview
2.8.2 Tuberculosis Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioMerieux Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hain Lifescience
2.9.1 Business Overview
2.9.2 Tuberculosis Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hain Lifescience Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Oxford Immunotec
2.10.1 Business Overview
2.10.2 Tuberculosis Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Oxford Immunotec Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Epistem
2.11.1 Business Overview
2.11.2 Tuberculosis Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Epistem Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.12 Akonni Biosystems
2.12.1 Business Overview
2.12.2 Tuberculosis Diagnostics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Akonni Biosystems Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.13 Creative Diagnostics
2.13.1 Business Overview
2.13.2 Tuberculosis Diagnostics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Creative Diagnostics Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Tuberculosis Diagnostics Market Competition, by Players
3.1 Global Tuberculosis Diagnostics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnostics Players Market Share
3.2.2 Top 10 Tuberculosis Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Tuberculosis Diagnostics Market Size by Regions
4.1 Global Tuberculosis Diagnostics Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
4.3 Europe Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
4.5 South America Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
5 North America Tuberculosis Diagnostics Revenue by Countries
5.1 North America Tuberculosis Diagnostics Revenue by Countries (2014-2019)
5.2 USA Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
5.3 Canada Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
5.4 Mexico Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
6 Europe Tuberculosis Diagnostics Revenue by Countries
6.1 Europe Tuberculosis Diagnostics Revenue by Countries (2014-2019)
6.2 Germany Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
6.3 UK Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
6.4 France Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
6.5 Russia Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
6.6 Italy Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Tuberculosis Diagnostics Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnostics Revenue by Countries (2014-2019)
7.2 China Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
7.3 Japan Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
7.4 Korea Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
7.5 India Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
8 South America Tuberculosis Diagnostics Revenue by Countries
8.1 South America Tuberculosis Diagnostics Revenue by Countries (2014-2019)
8.2 Brazil Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
8.3 Argentina Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
8.4 Colombia Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Tuberculosis Diagnostics by Countries
9.1 Middle East and Africa Tuberculosis Diagnostics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
9.3 UAE Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
9.4 Egypt Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
9.6 South Africa Tuberculosis Diagnostics Revenue and Growth Rate (2014-2019)
10 Global Tuberculosis Diagnostics Market Segment by Type
10.1 Global Tuberculosis Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Global Tuberculosis Diagnostics Market Forecast by Type (2019-2024)
10.3 Culture-based Revenue Growth Rate (2014-2024)
10.4 Sputum Smear Microscopy Revenue Growth Rate (2014-2024)
10.5 Rapid Molecular Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Tuberculosis Diagnostics Market Segment by Application
11.1 Global Tuberculosis Diagnostics Revenue Market Share by Application (2014-2019)
11.2 Tuberculosis Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Tuberculosis Diagnostics Market Size Forecast (2019-2024)
12.1 Global Tuberculosis Diagnostics Market Size Forecast (2019-2024)
12.2 Global Tuberculosis Diagnostics Market Forecast by Regions (2019-2024)
12.3 North America Tuberculosis Diagnostics Revenue Market Forecast (2019-2024)
12.4 Europe Tuberculosis Diagnostics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Tuberculosis Diagnostics Revenue Market Forecast (2019-2024)
12.6 South America Tuberculosis Diagnostics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Tuberculosis Diagnostics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tuberculosis Diagnostics Picture
Table Product Specifications of Tuberculosis Diagnostics
Table Global Tuberculosis Diagnostics and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
